Despite falling prices and earnings, Shandong Jincheng Pharm...

Despite falling prices and earnings, Shandong Jincheng Pharmaceutical Group's high P/E ratio may indicate future outperformance. However, with limited growth and a market forecast of 41% expansion, the high P/E ratio could disappoint shareholders if it aligns with recent growth rates.